(Q71015613)

English

Safety of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the Flecainide and Propafenone Italian Study Investigators

scientific article published on 01 January 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607393%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Safety of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the Flecainide and Propafenone Italian Study Investigators (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607393%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

atrial fibrillation

1 reference

based on heuristic

inferred from title

author name string

M Chimienti

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607393%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

M T Cullen

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607393%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

G Casadei

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607393%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

language of work or name

0 references

publication date

1 January 1996

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607393%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

American Journal of Cardiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607393%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

77

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607393%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607393%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

60A-75A

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607393%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

A Study of the Use of Flecainide Acetate in the Long-Term Management of Cardiac Arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. Danish-Norwegian Flecainide Multicenter Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

Safety and efficacy of oral flecainide therapy in patients with atrioventricular re-entrant tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

Flecainide in quinidine-resistant atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

Flecainide acetate in the prevention of paroxysmal atrial fibrillation: a nine-month follow-up of more than 500 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

Mortality in patients treated with flecainide and encainide for supraventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

New drug application strategies for supraventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

Usefulness of propafenone for recurrent paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

Propafenone for paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

Propafenone for prevention of recurrent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

Long-term safety and efficacy of flecainide in the treatment of supraventricular tachyarrhythmias: the United States experience. The Flecainide Supraventricular Tachyarrhythmia Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989119-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-9149(97)89119-9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607393%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607393%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71015613&oldid=2032817372"